Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics

被引:100
作者
Mogi, Tatsushi [1 ]
Kita, Kiyoshi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan
基金
日本学术振兴会;
关键词
Bacterial membrane; Cationic peptide antibiotics; Drug target; Gramicidin S; Polymyxin; Respiratory enzymes; NEGATIVE BACTERIAL-INFECTIONS; IN-VITRO; PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; ACINETOBACTER-BAUMANNII; HEMOLYTIC ACTIVITIES; POTENT INHIBITOR; QUINOL OXIDASE; RING SIZE; MEMBRANE;
D O I
10.1007/s00018-009-0129-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gramicidin S and polymyxins are small cationic cyclic peptides and act as potent antibiotics against Gram-negative and Gram-positive bacteria by perturbing integrity of the bacterial membranes. Screening of a natural antibiotics library with bacterial membrane vesicles identified gramicidin S as an inhibitor of cytochrome bd quinol oxidase and an alternative NADH dehydrogenase (NDH-2) and polymyxin B as an inhibitor of NDH-2 and malate: quinone oxidoreductase. Our studies showed that cationic cyclic peptide antibiotics have novel molecular targets in the membrane and interfere ligand binding on the hydrophobic surface of enzymes. Improvement of the toxicity and optimization of the structures and clinical uses are urgently needed for their effective application in combating drug-resistant bacteria.
引用
收藏
页码:3821 / 3826
页数:6
相关论文
共 64 条
[1]   ANTIMICROBIAL SPECIFICITY AND HEMOLYTIC-ACTIVITY OF CYCLIZED BASIC AMPHIPHILIC BETA-STRUCTURAL MODEL PEPTIDES AND THEIR INTERACTIONS WITH PHOSPHOLIPID-BILAYERS [J].
ANDO, S ;
NISHIKAWA, H ;
TAKIGUCHI, H ;
LEE, S ;
SUGIHARA, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1147 (01) :42-49
[2]   Polymyxin antibiotics for gram-negative infections [J].
Arnold, Tamra M. ;
Forrest, Graeme N. ;
Messmer, Karen J. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (08) :819-826
[3]   The antimicrobial peptide gramicidin S permeabilizes phospholipid bilayer membranes without forming discrete ion channels [J].
Ashrafuzzaman, Md. ;
Andersen, O. S. ;
McElhaney, R. N. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (12) :2814-2822
[4]   A re-evaluation of the role of host defence peptides in mammalian immunity [J].
Bowdish, DME ;
Davidson, DJ ;
Hancock, REW .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2005, 6 (01) :35-51
[5]   New targets and screening approaches in antimicrobial drug discovery [J].
Brown, ED ;
Wright, GD .
CHEMICAL REVIEWS, 2005, 105 (02) :759-774
[6]   Computational structure-based redesign of enzyme activity [J].
Chen, Cheng-Yu ;
Georgiev, Ivelin ;
Anderson, Amy C. ;
Donald, Bruce R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3764-3769
[7]   ANTIBACTERIAL ACTION OF COLISTIN (POLYMYXIN-E) AGAINST MYCOBACTERIUM-AURUM [J].
DAVID, HL ;
RASTOGI, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) :701-707
[8]   Interruption of the cydB focus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection [J].
Endley, S ;
McMurray, D ;
Ficht, TA .
JOURNAL OF BACTERIOLOGY, 2001, 183 (08) :2454-2462
[9]   Polymyxin B sulfate and colistin: Old antibiotics for emerging multiresistant gram-negative bacteria [J].
Evans, ME ;
Feola, DJ ;
Rapp, RP .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :960-967
[10]   Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].
Falagas, ME ;
Kasiakou, SK .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341